Next Century Growth Investors LLC Exagen Inc. Transaction History

Next Century Growth Investors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$11.0 - $16.7 $2.79 Million - $4.23 Million	-253,288 Closed	0 $0
Q1 2020 May 14, 2020	SELL	$12.7 - $25.95 $92,925 - $189,876	-7,317 Reduced 2.81%	253,288 $4.04 Million
Q4 2019 Feb 14, 2020	BUY	$12.61 - $28.48 $829,801 - $1.87 Million	65,805 Added 33.78%	260,605 $6.62 Million
Q3 2019 Nov 14, 2019	BUY	$14.5 - $17.5 $2.82 Million - $3.41 Million	194,800 New	194,800 $3.02 Million

6.21M

1.6K

4.1K

Ticker XGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 16,260,400
Market Cap $28.3M
Description
Exagen Inc. develops and commercializes various testing products based on its cell-bound complement activation products technology under the AVISE brand in the United States. It enables rheumatologists to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus ery...

Get notified when there are updates to the investment portfolio of Next Century Growth Investors LLC, based on Form 13F filings with the SEC.

Stay updated on Next Century Growth Investors LLC with notifications on news.